Companies House does not verify the accuracy of the information filed

SHIRE PHARMACEUTICALS LIMITED

Company number 02031674

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
10 Jul 2024	CS01	Confirmation statement made on 28 June 2024 with no updates	View PDF Confirmation statement made on 28 June 2024 with no updates - link opens in a new window - 3 pages (3 pages)
07 Apr 2024	AA	Full accounts made up to 31 March 2023	View PDF Full accounts made up to 31 March 2023 - link opens in a new window - 26 pages (26 pages)
19 Feb 2024	CH01	Director's details changed for Ms Seyda Atadan Memis on 1 September 2023	View PDF Director's details changed for Ms Seyda Atadan Memis on 1 September 2023 - link opens in a new window - 2 pages (2 pages)
17 Jul 2023	AA	Full accounts made up to 31 March 2022	View PDF Full accounts made up to 31 March 2022 - link opens in a new window - 32 pages (32 pages)
07 Jul 2023	CS01	Confirmation statement made on 28 June 2023 with updates	View PDF Confirmation statement made on 28 June 2023 with updates - link opens in a new window - 4 pages (4 pages)
10 Jun 2023	DISS40	Compulsory strike-off action has been discontinued	View PDF Compulsory strike-off action has been discontinued - link opens in a new window - 1 page (1 page)
06 Jun 2023	GAZ1	First Gazette notice for compulsory strike-off	View PDF First Gazette notice for compulsory strike-off - link opens in a new window - 1 page (1 page)
02 Jun 2023	TM02	Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023	View PDF Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023 - link opens in a new window - 1 page (1 page)
26 Jan 2023	TM01	Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023	View PDF Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023 - link opens in a new window - 1 page (1 page)
10 Nov 2022	TM01	Termination of appointment of Mark Gibbons as a director on 8 November 2022	View PDF Termination of appointment of Mark Gibbons as a director on 8 November 2022 - link opens in a new window - 1 page (1 page)
23 Aug 2022	AP01	Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022	View PDF Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022 - link opens in a new window - 2 pages (2 pages)
04 Jul 2022	CS01	Confirmation statement made on 28 June 2022 with updates	View PDF Confirmation statement made on 28 June 2022 with updates - link opens in a new window - 4 pages (4 pages)
18 May 2022	AA	Full accounts made up to 1 April 2021	View PDF Full accounts made up to 1 April 2021 - link opens in a new window - 38 pages (38 pages)
21 Mar 2022	AP01	Appointment of Peter Michael Grubin as a director on 1 March 2022	View PDF Appointment of Peter Michael Grubin as a director on 1 March 2022 - link opens in a new window - 2 pages (2 pages)
21 Mar 2022	TM01	Termination of appointment of Kentaro Shirahata as a director on 1 March 2022	View PDF Termination of appointment of Kentaro Shirahata as a director on 1 March 2022 - link opens in a new window - 1 page (1 page)
09 Jul 2021	CS01	Confirmation statement made on 28 June 2021 with updates	View PDF Confirmation statement made on 28 June 2021 with updates - link opens in a new window - 4 pages (4 pages)
15 Mar 2021	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
15 Mar 2021	SH19	Statement of capital on 15 March 2021 GBP 1	View PDF Statement of capital on 15 March 2021 GBP 1 - link opens in a new window - 3 pages (3 pages)
15 Mar 2021	CAP-SS	Solvency Statement dated 08/03/21	View PDF Solvency Statement dated 08/03/21 - link opens in a new window - 2 pages (2 pages)
15 Mar 2021	RESOLUTIONS	Resolutions RES13 ‐ Cancel share prem a/c 08/03/2021 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Cancel share prem a/c 08/03/2021 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 3 pages (3 pages)
11 Mar 2021	AA01	Current accounting period extended from 31 December 2020 to 31 March 2021	View PDF Current accounting period extended from 31 December 2020 to 31 March 2021 - link opens in a new window - 1 page (1 page)
30 Nov 2020	AP01	Appointment of Mr Kentaro Shirahata as a director on 30 November 2020	View PDF Appointment of Mr Kentaro Shirahata as a director on 30 November 2020 - link opens in a new window - 2 pages (2 pages)
30 Nov 2020	TM01	Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020	View PDF Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020 - link opens in a new window - 1 page (1 page)
05 Nov 2020	AA	Full accounts made up to 31 December 2019	View PDF Full accounts made up to 31 December 2019 - link opens in a new window - 35 pages (35 pages)
02 Jul 2020	CS01	Confirmation statement made on 28 June 2020 with updates	View PDF Confirmation statement made on 28 June 2020 with updates - link opens in a new window - 4 pages (4 pages)

Cookies on Companies House services

SHIRE PHARMACEUTICALS LIMITED

Filter by category